Cancer and Metabolic Disorders Linked with Testosterone Levels in Both Sexes but with Differences

Cancer and Metabolic Disorders Linked with Testosterone Levels in Both Sexes, but with Differences

08:00 EST 11 Feb 2020 | Genetic Engineering News

Having genetically higher testosterone levels increases the risk of metabolic diseases such as type 2 diabetes in women, but reduces the risk in men, according to the results of research by scientists in the U.K. The findings, from the largest study to date on the genetic regulation of sex hormone levels, also found that higher testosterone levels increase the risks of breast and endometrial cancers in women, and the risk of prostate cancer in men.

More From BioPortfolio on "Cancer and Metabolic Disorders Linked with Testosterone Levels in Both Sexes, but with Differences"